TSE:MRV Nuvo Pharmaceuticals (MRV) Stock Price, News & Analysis C$48.51 0.00 (0.00%) As of 06/30/2026 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsBuy This Stock About Nuvo Pharmaceuticals Stock (TSE:MRV) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Nuvo Pharmaceuticals alerts:Sign Up Key Stats Today's RangeC$45.06▼C$48.8350-Day Range N/A52-Week RangeC$26.00▼C$53.75Volume156,431 shsAverage Volume114,964 shsMarket CapitalizationC$42.44 billionP/E Ratio16.67Dividend Yield0.02%Price TargetN/AConsensus RatingN/A Company Overview To deliver the data infrastructure technology that connects the world, we're building solutions on the most powerful foundation: our partnerships with our customers. Trusted by the world's leading technology companies for over 25 years, we move, store, process and secure the world's data with semiconductor solutions designed for our customers' current needs and future ambitions. Through a process of deep collaboration and transparency, we're ultimately changing the way tomorrow's enterprise, cloud, automotive, and carrier architectures transform-for the better. Read More Receive MRV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nuvo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MRV Stock News HeadlinesHoldco Nuvo Group Dg Ltd Share ChatAugust 14, 2024 | lse.co.ukHoldco Nuvo Group D.G Ltd (NUVO)May 17, 2024 | finance.yahoo.comEarth's biggest energy source: near Grand CanyonThe largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - and much of it sits beneath the desert near the Grand Canyon. A drilling crew just hit the DOE's 2035 targets twelve years early, with costs down 50% in 18 months. Google signed on, Gates invested, and the Pentagon made it a priority. One company has been quietly building this infrastructure for sixty years.July 2 at 1:00 AM | Behind the Markets (Ad)Taro Pharmaceutical Industries Ltd.February 13, 2024 | wsj.comIonis Pharmaceuticals Inc IONSJanuary 30, 2024 | morningstar.comMNuvoco Vistas Corporation Ltd (NUVO)December 29, 2023 | uk.investing.comLIPO Lipella Pharmaceuticals Inc.November 22, 2023 | seekingalpha.comClosing Bell: Nuvo Pharmaceuticals Inc flat on Wednesday (MRV)April 17, 2023 | theglobeandmail.comSee More Headlines MRV Stock Analysis - Frequently Asked Questions How have MRV shares performed this year? Nuvo Pharmaceuticals' stock was trading at C$26.30 on May 7, 2026. Since then, MRV shares have increased by 84.4% and is now trading at C$48.51. How do I buy shares of Nuvo Pharmaceuticals? Shares of MRV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Nuvo Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some other companies that Nuvo Pharmaceuticals investors own include Biora Therapeutics (BIOR), ACM Research (ACMR), Achieve Life Sciences (ACHV), Achilles Therapeutics (ACHL), Adicet Bio (ACET), Air Canada (AC). Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolTSE:MRV CIKN/A Webwww.miravohealthcare.com PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)C$2.91 Trailing P/E Ratio16.67 Forward P/E Ratio704.65 P/E GrowthN/ANet IncomeC$15.17 million Net Margins20.95% Pretax MarginN/A Return on Equity1,180.47% Return on Assets5.85% Debt Debt-to-Equity Ratio1,165.85 Current Ratio2.11 Quick Ratio1.68 Sales & Book Value Annual SalesC$8.72 billion Price / Sales4.87 Cash FlowC$214.74 per share Price / Cash Flow0.23 Book ValueC$0.75 per share Price / Book64.68Miscellaneous Outstanding Shares874,800,000Free FloatN/AMarket CapC$42.44 billion OptionableNot Optionable Beta0.92 Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (TSE:MRV) was last updated on 7/2/2026 by MarketBeat.com Staff. From Our PartnersWhat Happens to Your Assets If You Die Without a Will?Without a will, your state's intestacy laws decide how your assets are divided — a rigid formula that ignores ...SmartAsset | SponsoredUrgent exposé on the "Mar-a-Lago Trade"Dr. David Eifrig, former Goldman Sachs VP and Senior Partner at Stansberry Research, has released an urgent ex...Stansberry Research | SponsoredGreatest Hedge Fund Manager of All Time: Get Out of StocksRay Dalio - who has made more money for clients than any hedge fund manager in history - is warning of a histo...TradeSmith | SponsoredThe pre-flight check for options tradersPilots never skip their pre-flight checklist - and neither should options traders. The Smart Trade Options Che...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredElon Is Quietly Doubling Down on This Bizarre AssetYahoo Finance reports this technology 'May Unlock $400 Trillion' - and Bloomberg calls it 'unavoidable.' Elon ...Brownstone Research | SponsoredThe Starlink of EnergyA portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvo Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvo Pharmaceuticals With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
